Current Treatment Options In Oncology

Journal Title：Current Treatment Options In Oncology

This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.

本期刊旨在回顾肿瘤学领域最重要的、最近发表的治疗方案进展。通过提供国际专家的清晰、有见地、平衡的贡献，本期刊旨在促进全球癌症治疗方法的发展。

我们通过任命国际权威人士担任关键主题领域的分部编辑来实现这一目标，这些主题包括内分泌肿瘤、淋巴瘤、神经肿瘤学以及乳腺癌、头颈癌、肺癌、皮肤癌、胃肠道癌和泌尿生殖系统癌。分部编辑则选择由顶尖专家撰写综合评论文章的主题，这些文章强调新发展和最近发表的重要论文，并通过带注释的参考文献列表突出显示。我们还提供知名肿瘤学家的评论，国际编辑委员会审查年度目录，推荐对其国家/地区特别感兴趣的文章，并确保主题是最新的并包括新兴研究。

Current Treatment Options In Oncology创刊于2000年，由Springer US出版商出版，收稿方向涵盖ONCOLOGY全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 12周，或约稿 ，影响因子指数3.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。